- Home
- NEON vs AEON Comparison
NEON vs AEON Comparison
Compare NEON & AEON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NEON | AEON |
|---|---|---|
| Founded | 1997 | N/A |
| Country | Sweden | United States |
| Employees | N/A | 8 |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 27.5M | 25.8M |
| IPO Year | 1994 | N/A |
Fundamental Metrics
Financial Performance| Metric | NEON | AEON |
|---|---|---|
| Price | $1.80 | $0.80 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | $6.00 | ★ $7.20 |
| AVG Volume (30 Days) | ★ 96.9K | 67.6K |
| Earning Date | 05-13-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 37.88 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $3,108,000.00 | N/A |
| Revenue This Year | $72.74 | N/A |
| Revenue Next Year | $28.94 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.27 | $0.53 |
| 52 Week High | $29.90 | $1.45 |
Technical Indicators
Market Signals| Indicator | NEON | AEON |
|---|---|---|
| Relative Strength Index (RSI) | 57.55 | 35.97 |
| Support Level | $1.66 | $0.70 |
| Resistance Level | $1.91 | $0.82 |
| Average True Range (ATR) | 0.11 | 0.06 |
| MACD | 0.00 | -0.01 |
| Stochastic Oscillator | 67.14 | 22.00 |
Price Performance
Historical ComparisonAbout NEON Neonode Inc.
Neonode Inc provides software solutions for machine perception that feature machine learning algorithms to detect and track persons and objects in video streams from cameras and other types of imagers. Its machine perception solutions are based on the MultiSensing technology platform. The company also offers optical sensing solutions for contactless touch and gesture sensing. It markets and sells its solutions mainly to customers in the automotive sector, along with other markets such as office equipment, industrial automation, medical, military, and avionics. Geographically, the company operates in Japan, South Korea, Germany, Sweden, China, and other regions, with a majority of its revenue generated from Japan.
About AEON AEON Biopharma Inc.
AEON Biopharma Inc is a biopharmaceutical company focused on the development of ABP-450 (prabotulinumtoxinA), a biosimilar to Botox (onabotulinumtoxinA), for therapeutic indications. The company is advancing ABP-450 through the biosimilar regulatory pathway and holds development and commercialization rights across multiple international markets.